SI2121553T1 - Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov - Google Patents
Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatovInfo
- Publication number
- SI2121553T1 SI2121553T1 SI200830708T SI200830708T SI2121553T1 SI 2121553 T1 SI2121553 T1 SI 2121553T1 SI 200830708 T SI200830708 T SI 200830708T SI 200830708 T SI200830708 T SI 200830708T SI 2121553 T1 SI2121553 T1 SI 2121553T1
- Authority
- SI
- Slovenia
- Prior art keywords
- preparation
- therapeutically valuable
- derivatives
- triphenylbutene derivatives
- valuable triphenylbutene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/30—Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88983807P | 2007-02-14 | 2007-02-14 | |
PCT/FI2008/050057 WO2008099059A1 (en) | 2007-02-14 | 2008-02-13 | Method for the preparation of therapeutically valuable triphenylbutene derivatives |
EP08718510A EP2121553B1 (en) | 2007-02-14 | 2008-02-13 | Method for the preparation of therapeutically valuable triphenylbutene derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2121553T1 true SI2121553T1 (sl) | 2012-11-30 |
Family
ID=39271403
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200830708T SI2121553T1 (sl) | 2007-02-14 | 2008-02-13 | Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov |
SI200831331T SI2518039T1 (sl) | 2007-02-14 | 2008-02-13 | Postopek za pripravo terapevtsko dragocenih derivatov trifenilbutena |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200831331T SI2518039T1 (sl) | 2007-02-14 | 2008-02-13 | Postopek za pripravo terapevtsko dragocenih derivatov trifenilbutena |
Country Status (19)
Country | Link |
---|---|
US (2) | US7812197B2 (sl) |
EP (3) | EP2518039B8 (sl) |
JP (1) | JP5363344B2 (sl) |
KR (1) | KR101510646B1 (sl) |
CN (1) | CN101636372B (sl) |
AU (1) | AU2008214530B2 (sl) |
BR (2) | BRPI0807675B1 (sl) |
CA (1) | CA2677861C (sl) |
CY (1) | CY1113184T1 (sl) |
DK (1) | DK2121553T3 (sl) |
ES (3) | ES2389961T3 (sl) |
HK (2) | HK1139379A1 (sl) |
HR (1) | HRP20141107T1 (sl) |
MX (1) | MX2009008660A (sl) |
PL (1) | PL2121553T3 (sl) |
PT (1) | PT2121553E (sl) |
RU (1) | RU2465261C2 (sl) |
SI (2) | SI2121553T1 (sl) |
WO (1) | WO2008099059A1 (sl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2121553T1 (sl) * | 2007-02-14 | 2012-11-30 | Hormos Medical Ltd | Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov |
EP2526080B1 (en) * | 2010-01-19 | 2014-03-26 | Cambrex Karlskoga AB | New processes for producing benzophenone derivatives |
KR101308258B1 (ko) * | 2010-10-15 | 2013-09-13 | 씨제이제일제당 (주) | 엔독시펜의 신규한 제조 방법 |
US9321712B2 (en) | 2012-10-19 | 2016-04-26 | Fermion Oy | Process for the preparation of ospemifene |
WO2014060640A1 (en) | 2012-10-19 | 2014-04-24 | Fermion Oy | A process for the preparation of ospemifene |
CN103739456A (zh) * | 2013-12-03 | 2014-04-23 | 镇江圣安医药有限公司 | 2-(对-((z-4-氯-1,2-二苯基-1-丁烯基)苯氧基)乙醇的新型衍生物及其应用 |
CN104788300B (zh) * | 2014-01-22 | 2017-01-11 | 南京华威医药科技开发有限公司 | 欧司哌米芬多晶型 |
CN104230723B (zh) * | 2014-08-21 | 2016-08-24 | 凯莱英医药集团(天津)股份有限公司 | 托瑞米芬的合成方法 |
WO2016043189A1 (ja) * | 2014-09-16 | 2016-03-24 | 塩野義製薬株式会社 | トリフェニルブテン誘導体の製造方法 |
US9975832B2 (en) * | 2014-12-29 | 2018-05-22 | Olon S.P.A. | Process for the preparation of ospemifene and fispemifene |
US10138190B2 (en) | 2015-01-09 | 2018-11-27 | Glenmark Pharmaceuticals Limited | Process for preparation of ospemifene |
EA039048B1 (ru) | 2016-03-15 | 2021-11-26 | Сионоги Энд Ко., Лтд. | Способ получения производных феноксиэтанола |
KR20240041745A (ko) | 2022-09-23 | 2024-04-01 | 김민정 | 입체음향 베개 |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2641075C2 (de) * | 1975-09-29 | 1985-11-14 | The Regents Of The University Of California, Berkeley, Calif. | Verfahren zur Herstellung von symmetrischen Olefinen |
JPS5422313A (en) | 1977-07-22 | 1979-02-20 | Kougai Boushi Chiyousa Kenkiyu | Process for preparing nnformylamine |
US4656187A (en) | 1981-08-03 | 1987-04-07 | Eli Lilly And Company | Treatment of mammary cancer |
GB2126576B (en) | 1982-06-25 | 1985-06-19 | Farmos Group Limited | Alkane and alkene derivatives |
FI77839C (fi) * | 1982-05-27 | 1989-05-10 | Farmos Oy | Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat. |
US5491173A (en) | 1982-06-25 | 1996-02-13 | Orion-Yhtyma Oy | Tri-phenyl alkene derivatives and their preparation and use |
US4729999A (en) | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
US4935243A (en) | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
US5189212A (en) | 1990-09-07 | 1993-02-23 | University Of Georgia Research Foundation, Inc. | Triarylethylene carboxylic acids with estrogenic activity |
US5219548A (en) | 1990-10-01 | 1993-06-15 | Board Of Regents, The University Of Texas System | High affinity halogenated-tamoxifen derivatives and uses thereof |
US6096874A (en) | 1990-10-01 | 2000-08-01 | Board Of Regents, The University Of Texas System | High affinity tamoxifen derivatives |
JPH06504522A (ja) | 1990-10-01 | 1994-05-26 | ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム | 高親和性タモキシフェン誘導体とその使用 |
US5118667A (en) | 1991-05-03 | 1992-06-02 | Celtrix Pharmaceuticals, Inc. | Bone growth factors and inhibitors of bone resorption for promoting bone formation |
US5196435A (en) | 1991-11-21 | 1993-03-23 | Eli Lilly And Company | Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma |
GB9207437D0 (en) | 1992-04-03 | 1992-05-20 | Orion Yhtymae Oy | Topical administration of toremifene and its metabolites |
US5352699A (en) | 1992-04-30 | 1994-10-04 | University Of Massachusetts Medical Center | Use of retinioc acid to treat vaginal atrophy |
US5446203A (en) | 1992-08-25 | 1995-08-29 | New York University | Synthesis of haloenones and aryl or alkyl substituted enones or alkenes |
DE4335876A1 (de) | 1993-10-17 | 1995-04-20 | Schering Ag | Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen |
US5461064A (en) | 1993-12-21 | 1995-10-24 | Eli Lilly And Company | Methods of inhibiting atrophy of the skin and vagina |
US5650425A (en) | 1994-04-04 | 1997-07-22 | Pharmos Corporation | Permanently ionic derivatives of steroid hormones and their antagonists |
US5681835A (en) | 1994-04-25 | 1997-10-28 | Glaxo Wellcome Inc. | Non-steroidal ligands for the estrogen receptor |
US5604248A (en) | 1994-05-05 | 1997-02-18 | Eli Lilly And Company | Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
US5470883A (en) | 1994-05-23 | 1995-11-28 | Stromberg; Brent V. | Method of treating peripheral vasoconstriction with tamoxifen citrate |
FI100692B (fi) | 1994-05-24 | 1998-02-13 | Leiras Oy | Menetelmä farmaseuttisten koostumusten valmistamiseksi, jolloin koostu mukset pohjautuvat mikroemulsiogeeleihin sekä uusia mikroemulsioihin p ohjautuvia geelejä |
US5441986A (en) | 1994-07-19 | 1995-08-15 | Pfizer Inc. | Estrogen agonists as remedies for prostate and cardiovascular diseases |
GB9418067D0 (en) | 1994-09-07 | 1994-10-26 | Orion Yhtymae Oy | Triphenylethylenes for the prevention and treatment of osteoporosis |
US5658931A (en) | 1994-09-20 | 1997-08-19 | Eli Lilly And Company | Method for inhibiting mammalian breast carcinoma with tamoxifen, and analogs thereof, and certain naphthyl compounds |
US6562862B1 (en) | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
JPH10509962A (ja) | 1994-11-29 | 1998-09-29 | ヘキスト・マリオン・ルセル・インコーポレイテツド | 骨粗鬆症の治療および予防におけるトリアリール−エチレン誘導体の使用方法 |
US5821254A (en) | 1995-02-17 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer |
GB9509572D0 (en) | 1995-05-11 | 1995-07-05 | Cancer Res Campaign Tech | Cancer therapy |
DE19526146A1 (de) | 1995-07-07 | 1997-01-09 | Schering Ag | Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
US5747059A (en) | 1996-01-11 | 1998-05-05 | Novo Nordisk A/S | Atrophy of skin/mucous membrane |
GB9604577D0 (en) * | 1996-03-04 | 1996-05-01 | Orion Yhtymae Oy | Serum cholesterol lowering agent |
DE19653736C2 (de) | 1996-12-12 | 2002-11-21 | Lancaster Group Gmbh | Kosmetisches Präparat mit Peptidzusatz |
GB9803521D0 (en) | 1998-02-19 | 1998-04-15 | Orion Yhtymo Oy | New compounds and pharmaceutical compositions thereof |
US6632447B1 (en) | 1998-05-07 | 2003-10-14 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US6525084B2 (en) | 1998-07-23 | 2003-02-25 | Novo Nordisk A/S | Stable pharmaceutical formulation |
US6245352B1 (en) | 1999-04-27 | 2001-06-12 | Eli Lilly And Company | Pharmaceutical formulation |
TW593256B (en) * | 1999-11-16 | 2004-06-21 | Hormos Medical Oy Ltd | Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
CO5271697A1 (es) | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona |
RU2342145C2 (ru) | 2000-01-28 | 2008-12-27 | Андорешерш, Инк. | Селективные модуляторы рецептора эстрогена в комбинации с эстрогенами |
US20010034340A1 (en) | 2000-03-20 | 2001-10-25 | American Home Products Corporation | Hormone replacement therapy |
US6245819B1 (en) | 2000-07-21 | 2001-06-12 | Hormos Medical Oy, Ltd. | Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause |
US6514898B2 (en) * | 2000-12-15 | 2003-02-04 | Shell Oil Company | Process of preparing a fluid rare earth alkoxylation catalyst |
FI111710B (fi) | 2001-05-04 | 2003-09-15 | Hormos Medical Oy Ltd | Menetelmä terapeuttisesti aktiivisen yhdisteen valmistamiseksi |
WO2003015820A1 (fr) | 2001-08-10 | 2003-02-27 | Takeda Chemical Industries, Ltd. | Medicaments combines d'agoniste de la gnrh |
CA2468719C (en) | 2001-11-29 | 2011-05-24 | Gtx Inc. | Prevention and treatment of androgen-deprivation induced osteoporosis |
US20070197664A1 (en) | 2001-11-29 | 2007-08-23 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
CA2484542C (en) | 2002-06-06 | 2010-11-02 | Hormos Medical Corporation | Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
US20040248989A1 (en) | 2003-06-05 | 2004-12-09 | Risto Santti | Method for the treatment or prevention of lower urinary tract symptoms |
US8236861B2 (en) | 2004-02-13 | 2012-08-07 | Hormos Medical Corporation | Method for enhancing the bioavailablity of ospemifene |
US20050187302A1 (en) | 2004-02-23 | 2005-08-25 | Hormos Medical Corporation | Method for treatment or prevention of osteoporosis in individuals with high bone turnover |
US8642079B2 (en) | 2004-02-23 | 2014-02-04 | Hormos Medical Corporation | Solid formulations of ospemifene |
JP2007523952A (ja) | 2004-02-25 | 2007-08-23 | スミスクライン ビーチャム コーポレーション | 選択的エストロゲンレセプターモジュレーターとして使用するための置換キノリン化合物 |
US8758821B2 (en) | 2004-05-04 | 2014-06-24 | Hormos Medical Ltd. | Oral formulations of ospemifene |
CA2578852A1 (en) | 2004-09-03 | 2006-03-09 | Hormos Medical Corporation | Use of a selective estrogen receptor modulator for the manufacture of a pharmaceutical preparation for use in a method for the treatment or prevention of androgen deficiency |
WO2008099060A2 (en) | 2007-02-14 | 2008-08-21 | Hormos Medical Ltd | Methods for the preparation of fispemifene from ospemifene |
SI2121553T1 (sl) | 2007-02-14 | 2012-11-30 | Hormos Medical Ltd | Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov |
-
2008
- 2008-02-13 SI SI200830708T patent/SI2121553T1/sl unknown
- 2008-02-13 CA CA2677861A patent/CA2677861C/en active Active
- 2008-02-13 KR KR1020097018000A patent/KR101510646B1/ko active IP Right Grant
- 2008-02-13 EP EP12173502.1A patent/EP2518039B8/en not_active Not-in-force
- 2008-02-13 EP EP08718510A patent/EP2121553B1/en not_active Not-in-force
- 2008-02-13 SI SI200831331T patent/SI2518039T1/sl unknown
- 2008-02-13 ES ES08718510T patent/ES2389961T3/es active Active
- 2008-02-13 ES ES12173502.1T patent/ES2524002T3/es active Active
- 2008-02-13 MX MX2009008660A patent/MX2009008660A/es active IP Right Grant
- 2008-02-13 CN CN2008800049951A patent/CN101636372B/zh active Active
- 2008-02-13 AU AU2008214530A patent/AU2008214530B2/en not_active Ceased
- 2008-02-13 PL PL08718510T patent/PL2121553T3/pl unknown
- 2008-02-13 RU RU2009134131/04A patent/RU2465261C2/ru not_active IP Right Cessation
- 2008-02-13 BR BRPI0807675-8A patent/BRPI0807675B1/pt not_active IP Right Cessation
- 2008-02-13 US US12/030,420 patent/US7812197B2/en active Active
- 2008-02-13 ES ES14178678.0T patent/ES2590262T3/es active Active
- 2008-02-13 JP JP2009549436A patent/JP5363344B2/ja active Active
- 2008-02-13 DK DK08718510.4T patent/DK2121553T3/da active
- 2008-02-13 PT PT08718510T patent/PT2121553E/pt unknown
- 2008-02-13 BR BRPI0823326-8A patent/BRPI0823326B1/pt not_active IP Right Cessation
- 2008-02-13 WO PCT/FI2008/050057 patent/WO2008099059A1/en active Application Filing
- 2008-02-13 EP EP14178678.0A patent/EP2821385B1/en not_active Not-in-force
-
2010
- 2010-06-03 HK HK10105507.3A patent/HK1139379A1/xx not_active IP Right Cessation
- 2010-09-16 US US12/883,680 patent/US8293947B2/en active Active
-
2012
- 2012-07-26 CY CY20121100670T patent/CY1113184T1/el unknown
-
2014
- 2014-11-14 HR HRP20141107AT patent/HRP20141107T1/hr unknown
-
2015
- 2015-07-06 HK HK15106438.0A patent/HK1206003A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1206003A1 (zh) | 有治療價值的三苯基丁烯衍生物的製備方法 | |
HK1141013A1 (en) | Process for the preparation of certain substituted sulfilimines | |
IL198847A0 (en) | New process for the preparation of 2-imino-thiazolidin-4-one derivatives | |
IL206100A0 (en) | Process for the preparation of macrocycle | |
HK1136559A1 (en) | Process for the preparation of a benzimidazole derivative | |
IL196875A0 (en) | Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines | |
ZA200905601B (en) | Improved process for the preparation of ozidized phospholipids | |
GB0702854D0 (en) | Method for the synthesis of sucrose-6-esters | |
ZA200907191B (en) | Process for the preparation of gefitiib | |
ZA201003241B (en) | Method for the preparation of morphine compounds | |
IL206530A0 (en) | Process for the preparation of 6-substituted-1-(2h)-isoquinolinones | |
IL205082A0 (en) | Process for the preparation of tetranorlabdane derivatives | |
PL2102174T3 (pl) | Sposób wytwarzania pochodnych podstawionych cyjanofenoksy-pirymidynyloksyfenyloakrylanów | |
SI2155679T1 (sl) | Metoda za pripravo derivatov 4-formilaminopiperidina | |
HUP0700756A2 (en) | Process for the preparation of pharmaceutical intermediers | |
IL207557A0 (en) | Process for the preparation of pregnane derivatives | |
EG26332A (en) | Process for the preparation of benzonoprons | |
ZA200901556B (en) | Process for the preparation of abacavir | |
ZA201000802B (en) | Process for the preparation of alfuzosin hydrochloride | |
HU0700818D0 (en) | Process for the preparation of polyirocyanates of the diphenylmethone series | |
EP2173695A4 (en) | PROCESS FOR THE PREPARATION OF CIS-4-TERT.-BUTYLCYCLOHEXANOL | |
GB2464854B (en) | Process for the preparation of risperidone | |
EG26107A (en) | Way to prepare medicine Alandral | |
IL200230A0 (en) | Method for the production of ??-ketonitriles | |
IL197408A0 (en) | Process for the preparation of abacavir |